1. Bridging Sunitinib Exposure to Time‐to‐Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker. (8th June 2016) Authors: Ait‐Oudhia, S; Mager, DE; Pokuri, V; Tomaszewski, G; Groman, A; Zagst, P; Fetterly, G; Iyer, R Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 5:Number 6(2016:Jun.) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗